Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.53 USD | -1.96% | +0.19% | -40.68% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 10M | Capitalization | 406M |
---|---|---|---|---|---|
Net income 2024 * | -66M | Net income 2025 * | -81M | EV / Sales 2024 * | - |
Net cash position 2024 * | 316M | Net cash position 2025 * | 437M | EV / Sales 2025 * | -3.06 x |
P/E ratio 2024 * |
-5.37
x | P/E ratio 2025 * |
-5.17
x | Employees | 44 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 77.39% |
Latest transcript on Tourmaline Bio, Inc.
1 day | -1.96% | ||
1 week | +0.19% | ||
Current month | -1.90% | ||
1 month | -31.31% | ||
3 months | -57.86% | ||
6 months | -2.14% | ||
Current year | -40.68% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 18 M€ | +3.68% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 15.53 | -1.96% | 223,976 |
24-05-03 | 15.84 | -0.50% | 191,659 |
24-05-02 | 15.92 | +1.34% | 469,952 |
24-05-01 | 15.71 | -0.76% | 304,163 |
24-04-30 | 15.83 | +2.13% | 249,644 |
Delayed Quote Nasdaq, May 06, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.68% | 406M | |
+9.15% | 105B | |
-1.08% | 104B | |
+5.79% | 22.94B | |
-11.55% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-9.91% | 16.96B | |
+7.55% | 14.16B | |
+40.04% | 12.63B |
- Stock Market
- Equities
- TRML Stock